...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
Message: Re: Scenario Analysis on end of BETonMACE Phase 3

From where I sit Resverlogix does a horrible job of managing expectations....so I'm managing my own.  It seems pretty much everyone has taken the 250 Event milestone taking place in April....that "expectation" has been taken to the bank with the funds already designated for deposit.  

What happens if April rolls into May with no news?

Based on past experience I think it would be pretty naive to expect the company to be proactive with an announcement of any kind before hand.

Personally I will take any further delays as a positive.....

 

Share
New Message
Please login to post a reply